Nephros Inc NEPH
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if NEPH is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $2.17
- Day Range
- $2.06–2.15
- 52-Week Range
- $0.99–4.04
- Bid/Ask
- $0.85 / $2.46
- Market Cap
- $22.25 Mil
- Volume/Avg
- 17,336 / 28,970
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1.54
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Growth
- Total Number of Employees
- 27
- Website
- https://www.nephros.com
Valuation
Metric
|
NEPH
|
---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 2.66 |
Price/Sales | 1.54 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
Metric
|
NEPH
|
---|---|
Quick Ratio | 2.75 |
Current Ratio | 3.98 |
Interest Coverage | −818.50 |
Quick Ratio
NEPH
Profitability
Metric
|
NEPH
|
---|---|
Return on Assets (Normalized) | −2.07% |
Return on Equity (Normalized) | −2.84% |
Return on Invested Capital (Normalized) | −2.96% |
Return on Assets
NEPH
Medical Instruments & Supplies Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|
ISRG
| Intuitive Surgical Inc | Gylk | $139.2 Bil | |
BDX
| Becton Dickinson & Co | Rxkgpl | $68.7 Bil | |
ALC
| Alcon Inc | Fssfkdn | $41.9 Bil | |
CLPBY
| Coloplast A/S ADR | Lmv | $30.5 Bil | |
WST
| West Pharmaceutical Services Inc | Bymn | $29.0 Bil | |
RMD
| ResMed Inc | Yghdtt | $28.1 Bil | |
BAX
| Baxter International Inc | Trdlj | $21.1 Bil | |
COO
| The Cooper Companies Inc | Vkpfw | $20.0 Bil | |
HOLX
| Hologic Inc | Vxvtzkr | $17.9 Bil | |
TFX
| Teleflex Inc | Lwwfp | $10.2 Bil |